These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 6224427)

  • 1. An active model of immune complex glomerulonephritis in the rat employing cationized antigen.
    Oite T; Shimizu F; Kihara I; Batsford SR; Vogt A
    Am J Pathol; 1983 Aug; 112(2):185-94. PubMed ID: 6224427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative studies of in situ immune complex glomerulonephritis in the rat induced by planted, cationized antigen.
    Oite T; Batsford SR; Mihatsch MJ; Takamiya H; Vogt A
    J Exp Med; 1982 Feb; 155(2):460-74. PubMed ID: 6460074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular handling of immune complex in the acute phase of active in situ immune complex glomerulonephritis employing cationized ferritin in rats. Ultrastructural localization of immune complex, complements and inflammatory cells.
    Fujigaki Y; Nagase M; Kojima K; Yamamoto T; Hishida A
    Virchows Arch; 1997 Jul; 431(1):53-61. PubMed ID: 9247633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin.
    Camussi G; Pawlowski I; Saunders R; Brentjens J; Andres G
    J Lab Clin Med; 1987 Aug; 110(2):196-206. PubMed ID: 2955066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediator systems in a passive model of in situ immune complex glomerulonephritis. Role for complement, polymorphonuclear granulocytes and monocytes.
    Thaiss F; Batsford S; Mihatsch MJ; Heitz PU; Bitter-Suermann D; Vogt A
    Lab Invest; 1986 Jun; 54(6):624-35. PubMed ID: 2940417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultramicroscopic localization of cationized antigen in the glomerular basement membrane in the course of active, in situ immune complex glomerulonephritis.
    Oite T; Shimizu F; Suzuki Y; Vogt A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(2):107-18. PubMed ID: 2859686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immune complex glomerulopathy associated with glomerular capillary thrombosis in the laboratory mouse. A highly reproducible accelerated model utilizing cationized antigen.
    Sawtell NM; Weiss MA; Pesce AJ; Michael JG
    Lab Invest; 1987 Mar; 56(3):256-63. PubMed ID: 2434726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of formation of subepithelial electron-dense deposits in active in situ immune complex glomerulonephritis.
    Kagami S; Kawakami K; Okada K; Kuroda Y; Morioka T; Shimizu F; Oite T
    Am J Pathol; 1990 Mar; 136(3):631-9. PubMed ID: 1690511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In situ immune complex glomerulonephritis induced by perfusion of cationized antibody].
    Kawaguchi M
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1061-70. PubMed ID: 2287098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.
    Groggel GC; Adler S; Rennke HG; Couser WG; Salant DJ
    J Clin Invest; 1983 Dec; 72(6):1948-57. PubMed ID: 6227634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental immune complex glomerulonephritis in dogs receiving cationized bovine serum albumin.
    Wright NG; Mohammed NA; Eckersall PD; Nash AS
    Res Vet Sci; 1985 May; 38(3):322-8. PubMed ID: 3892609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement system promotes transfer of immune complex across glomerular filtration barrier.
    Fujigaki Y; Batsford SR; Bitter-Suermann D; Vogt A
    Lab Invest; 1995 Jan; 72(1):25-33. PubMed ID: 7837787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental glomerulonephritis in the isolated perfused rat kidney.
    Couser WG; Steinmuller DR; Stilmant MM; Salant DJ; Lowenstein LM
    J Clin Invest; 1978 Dec; 62(6):1275-87. PubMed ID: 372233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental glomerulonephritis in the mouse associated with mesangial deposition ofautologous ferritin immune complexes.
    Stilmant MM; Couser WG; Cotran RS
    Lab Invest; 1975 Jun; 32(6):746-56. PubMed ID: 125361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental glomerulonephritis induced by human IgG in rats.
    Yamamoto K; Oite T; Kihara I; Shimizu F
    Clin Exp Immunol; 1984 Sep; 57(3):575-82. PubMed ID: 6235995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesangial disposal of glomerular immune deposits in acute malarial glomerulonephritis of rats.
    Sterzel RB; Ehrich JH; Lucia H; Thomson D; Kashgarian M
    Lab Invest; 1982 Feb; 46(2):209-14. PubMed ID: 7038293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural studies in passive in situ immune complex glomerulonephritis. A rat model for membranous glomerulonephritis.
    Sasaki M; Batsford S; Thaiss F; Oite T; Vogt A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(2):173-80. PubMed ID: 2482573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive passive Heymann nephritis in the rat.
    Barabas AZ; Boyd N; Cornish J; Lannigan R
    Lab Invest; 1982 Oct; 47(4):400-5. PubMed ID: 6214666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK; Cavallo T
    Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of complement in immune complex glomerulonephritis induced by cationized antigen].
    Fukuda W; Takemura S; Yanagida K; Okamoto M; Kasamatsu Y; Deguchi M; Ueda M; Sugino S; Kondo M
    Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):897-903. PubMed ID: 2531243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.